Showing results (41-50 of 147) with videos related to
Sort By:
Pageof 15
Gynecologic Oncology Reports|August 28, 2023
Surgical and oncologic outcomes in surgically treated women 80 years and older with endometrioid endometrial cancer as a function of their comorbiditiesAbdelrahman AlAshqar, Maddie Ghazarian, Emily M Webster, et al.Journal of Surgical Oncology|June 1, 2012
Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian cancer (FIGO Stage IIIC and IV)Michelle A Glasgow, Herbert Yu, Thomas J Rutherford, et al.Gynecologic Oncology|January 24, 2007
Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV diseaseJune Y Hou, Michael G Kelly, Herbert Yu, et al.Gynecologic Oncology Reports|October 31, 2025
Adverse events beyond the RUBY trial: reporting immunotherapy-associated myocarditis, myositis, and myasthenia gravis in a real-world endometrial cancer caseYasmin Abozenah, Blair McNamara, Michelle Greenman, et al.Gynecologic Oncology|May 2, 2006
Atypical presentations of carboplatin hypersensitivity reactions: characterization and management in patients with gynecologic malignanciesJessica N McAlpine, Michael G Kelly, David M O'malley, et al.Gynecologic Oncology|July 12, 2005
Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapyMichael G Kelly, David M O'malley, Pei Hui, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 3, 2015
Factors Predictive of Improved Survival in Patients With Brain Metastases From Gynecologic Cancer: A Single Institution Retrospective Study of 47 Cases and Review of the LiteratureGregory M Gressel, Lisbet S Lundsberg, Gary Altwerger, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 18, 2011
Phase II evaluation of phenoxodiol in combination with cisplatin or paclitaxel in women with platinum/taxane-refractory/resistant epithelial ovarian, fallopian tube, or primary peritoneal cancersMichael G Kelly, Gil Mor, Alan Husband, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 4, 2009
Brain metastases in epithelial ovarian and primary peritoneal carcinomaElena S Ratner, Eugene Toy, David M O'Malley, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 11, 2014
Institutional review of primary non-hodgkin lymphoma of the female genital tract: a 33-year experienceAsima Kaleem Ahmad, Pei Hui, Babak Litkouhi, et al.Pageof 15